2025 Translational Research Award supports established investigators studying breast cancer metastases to develop better treatments and improve outcomes for people living with stage IV disease.
2025 Early Career Investigator Award supports emerging investigators studying established metastatic breast cancer through basic, translational, and clinical research to improve outcomes for people with stage IV disease.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
New Translational Science Tools and Methodologies Award supports research teams developing generalizable tools for preclinical research, therapy discovery, and clinical monitoring to advance new treatments.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Investigator Awards - Neuroendocrine Tumor Research Foundation support researchers pursuing basic, translational, and select clinical studies to advance neuroendocrine cancer detection and treatment.